Cargando…
An in silico epitope-based peptide vaccine design against the 2019-nCoV
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382968/ http://dx.doi.org/10.1186/s43042-020-00071-7 |
| _version_ | 1783563352570593280 |
|---|---|
| author | Durojaye, Olanrewaju Ayodeji Mushiana, Talifhani Cosmas, Samuel Ibiang, Glory Omini Ibiang, Mercy Omini |
| author_facet | Durojaye, Olanrewaju Ayodeji Mushiana, Talifhani Cosmas, Samuel Ibiang, Glory Omini Ibiang, Mercy Omini |
| author_sort | Durojaye, Olanrewaju Ayodeji |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7382968 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73829682020-07-28 An in silico epitope-based peptide vaccine design against the 2019-nCoV Durojaye, Olanrewaju Ayodeji Mushiana, Talifhani Cosmas, Samuel Ibiang, Glory Omini Ibiang, Mercy Omini Egypt J Med Hum Genet Correspondence Springer Berlin Heidelberg 2020-07-27 2020 /pmc/articles/PMC7382968/ http://dx.doi.org/10.1186/s43042-020-00071-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Durojaye, Olanrewaju Ayodeji Mushiana, Talifhani Cosmas, Samuel Ibiang, Glory Omini Ibiang, Mercy Omini An in silico epitope-based peptide vaccine design against the 2019-nCoV |
| title | An in silico epitope-based peptide vaccine design against the 2019-nCoV |
| title_full | An in silico epitope-based peptide vaccine design against the 2019-nCoV |
| title_fullStr | An in silico epitope-based peptide vaccine design against the 2019-nCoV |
| title_full_unstemmed | An in silico epitope-based peptide vaccine design against the 2019-nCoV |
| title_short | An in silico epitope-based peptide vaccine design against the 2019-nCoV |
| title_sort | in silico epitope-based peptide vaccine design against the 2019-ncov |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382968/ http://dx.doi.org/10.1186/s43042-020-00071-7 |
| work_keys_str_mv | AT durojayeolanrewajuayodeji aninsilicoepitopebasedpeptidevaccinedesignagainstthe2019ncov AT mushianatalifhani aninsilicoepitopebasedpeptidevaccinedesignagainstthe2019ncov AT cosmassamuel aninsilicoepitopebasedpeptidevaccinedesignagainstthe2019ncov AT ibianggloryomini aninsilicoepitopebasedpeptidevaccinedesignagainstthe2019ncov AT ibiangmercyomini aninsilicoepitopebasedpeptidevaccinedesignagainstthe2019ncov AT durojayeolanrewajuayodeji insilicoepitopebasedpeptidevaccinedesignagainstthe2019ncov AT mushianatalifhani insilicoepitopebasedpeptidevaccinedesignagainstthe2019ncov AT cosmassamuel insilicoepitopebasedpeptidevaccinedesignagainstthe2019ncov AT ibianggloryomini insilicoepitopebasedpeptidevaccinedesignagainstthe2019ncov AT ibiangmercyomini insilicoepitopebasedpeptidevaccinedesignagainstthe2019ncov |